TG Therapeutics Inc (TGTX)

[stockguard]

Also have $TGTX in the clinical trials ETF $BBC that has 53,943 shares. Institutional ownership has been picking up within the last quarter, plus 3 phase 3 trials in a well tolerate effective drug/drugs combo.

This is why I hold a non-trading position now:

NOW ENROLLING THE PHASE 2b UNITY-NHL TRIAL: Ublituximab + TGR-1202 Compared to TGR-1202 in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)


THE PHASE 3 ULTIMATE I & II TRIALS (ONGOING, BUT NO LONGER RECRUITING): Ublituximab as Compared to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (RMS); ULTIMATE I & ULTIMATE II


THE UNITY-CLL PHASE 3 TRIAL (ONGOING, BUT NO LONGER RECRUITING): Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients with Chronic Lymphocytic Leukemia (UNITY-CLL)


THE GENUINE PHASE 3 TRIAL (ONGOING, BUT NO LONGER RECRUITING): Ublituximab in Combination with Ibrutinib Versus Ibrutinib Alone in Patients with Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

http://www.tgtherapeutics.com/clinical-trials/index.cfm